Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: 250, P. 114564 - 114564
Published: Feb. 14, 2025
Language: Английский
Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: 250, P. 114564 - 114564
Published: Feb. 14, 2025
Language: Английский
Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: Feb. 3, 2025
Diabetes mellitus (DM) ranks among the most prevalent chronic metabolic diseases, characterized primarily by a persistent elevation in blood glucose levels. This condition typically stems from either insufficient insulin secretion or functional defect itself. Clinically, diabetes is classified into type 1 (T1DM) and 2 (T2DM), with T2DM comprising nearly 90% of all diagnosed cases. Notably, global incidence has surged dramatically over recent decades. The adenylate-activated protein kinase (AMPK) signaling pathway crucial regulating cellular energy metabolism, marking it as significant therapeutic target for related complications. Natural products, their diverse origins, multifaceted bioactivities, relative safety, hold considerable promise modulating AMPK pathway. review article explores advances research on natural products that pathway, aiming to inform development innovative antidiabetic therapies.
Language: Английский
Citations
0Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: 250, P. 114564 - 114564
Published: Feb. 14, 2025
Language: Английский
Citations
0